Even if a patient has already been diagnosed with breast cancer, the surgery can reduce risk of dying, finds a study of women with two common breast cancer genes. Preemptive removal of breasts or ovaries in women with two common breast cancer genes can sharply reduce the risk of contracting cancer and dying, even if a woman has already been diagnosed with breast cancer, a new study confirms.

Go to Original Source

Women carrying the BRCA1 and BRCA2 genetic mutations for breast cancer could benefit from having double mastectomies before they develop cancer. “We found mastectomy provided huge risk reduction of subsequent breast cancer diagnosis and death,” says the author of a new study.

Go to Original Source

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops antibody-based targeted anticancer products, announced that Genentech, a member of the Roche Group, announced its receipt of a Refuse to File (RTF) letter from the US Food and Drug Administration (FDA) for the accelerated approval of the Biologic License Application (BLA) for trastuzumab-DM1, or T-DM1, submitted in July 2010…

Go to Original Source

Breast Cancer Awareness month is just weeks away.  If you’re a breast cancer survivor, battling the disease or know someone who is we’re asking you to share your story with us.  As part of our Paint the Town Pink campaign thorughout the month of October we’ll be running breast cancer news stories, features and profiles on local people fighting, beating and living with breast cancer in our weekly …

Go to Original Source

A bracelet designed to support breast cancer awareness is raising some eyebrows at a California high school.

Go to Original Source